Drugs / PF-07291177
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05434091 | Aug 2022 → Mar 2023 | — | Pfizer | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-07291177 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05434091 ↗ |
| Route | Oral | “PF-07291177 will be prepared as an oral solution and/or suspension given” NCT05434091 ↗ |